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Abstract
MicroRNAs (miRNAs) are crucial for regulatory T cell (Treg) stability and function. We report that microRNA-10a (miR-10a) is
expressed in Tregs but not in other T cells including individual thymocyte subsets. Expression profiling in inbred mouse
strains demonstrated that non-obese diabetic (NOD) mice with a genetic susceptibility for autoimmune diabetes have lower
Treg-specific miR-10a expression than C57BL/6J autoimmune resistant mice. Inhibition of miR-10a expression in vitro leads
to reduced FoxP3 expression levels and miR-10a expression is lower in unstable ‘‘exFoxP3’’ T cells. Unstable in vitro TGF-ß-
induced, iTregs do not express miR-10a unless cultured in the presence of retinoic acid (RA) which has been associated with
increased stability of iTreg, suggesting that miR-10a might play a role in stabilizing Treg. However, genetic ablation of miR-
10a neither affected the number and phenotype of natural Treg nor the capacity of conventional T cells to induce FoxP3 in
response to TGFb, RA, or a combination of the two. Thus, miR-10a is selectively expressed in Treg but inhibition by
antagomiRs or genetic ablation resulted in discordant effects on FoxP3.
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Introduction
The successful use of regulatory T cells (Tregs) in various
preclinical models of inflammatory and autoimmune disease has
led to clinical trials using Tregs to treat or prevent graft versus host
disease, type 1 diabetes (T1D) and transplant rejection [1].
However, recent studies have suggested that mice and humans
harbor a small population of Tregs that lose the expression of the
crucial transcription factor, FoxP3, leading to instability, especially
under certain inflammatory conditions [2]. The so-called exFoxP3
cells have been shown to be potentially pathogenic [2]. The basis
for this instability and its effects on Treg suppressive activity
remains unclear.
microRNAs (miRNAs) are short, single-stranded RNA mole-
cules involved in maintaining immune homeostasis, particularly
during stress, such as inflammation, by fine-tuning gene expression
post-transcriptionally [3]. Dicer-deficient Tregs are extremely
unstable, unable to maintain immune homeostasis leading to a
scurfy-like, autoimmune disease [4,5,6]. In addition to Dicer,
Drosha [6] and DGCR8 (Jeker and Bluestone, unpublished
observation), two proteins of the microprocessor complex involved
in the biogenesis of miRNAs, are also essential for Treg function.
Thus, as a class of regulatory genes, miRNAs are critical for Treg
development, function and lineage stability [4,5,6,7]. In contrast,
very little is known about the role of individual miRNAs in Tregs.
Results
Treg miRNA Expression Signature
Only a limited number of miRNAs have been previously
reported to be differentially expressed in Treg versus Tconv [7].
We generated a Treg-specific miRNA profile by using FoxP3-
driven GFP reporter mice [4] to distinguish Treg from Tconv
cells. miRNA microarray analysis of Tconv (.99% purity) and
Treg cells (.98% purity) identified mostly miRNAs expressed in
both cell types with some being expressed at quantitatively
different levels (Fig. 1a and Table S1). miR-10a was the only
miRNA exclusively detected in Treg when compared to Tconv
(Fig. 1a). The differential expression of miR-10a was confirmed by
qPCR on RNA from freshly purified CD4
+GFP
- Tconv and
CD4
+GFP
+ Treg populations from FoxP3-GFP reporter [8] and
FoxP3-GFP-hCre reporter mice (Fig. 1b). miR-10a was readily
detected in Treg cells (n.7 independent experiments). In contrast,
there was either no or minimal signal with high variability when
RNA from Tconv cells was examined. Similar results were
observed with Tregs isolated from non-transgenic C57BL/6J (B6)
mice isolated based on phenotypic expression markers
(CD4
+CD25
+CD62L
hi cells) (data not shown). miR-10a expression
was similar in Tregs independent of sex or age (5 weeks to 16
weeks old mice) (data not shown).
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To validate the expression profiling, we analyzed miR-10a
expression by qPCR in various purified cell populations from
FoxP3-GFP or FoxP3-GFP-hCre reporter mice. We purified
CD4
-CD8
- double negative (DN), CD4
+CD8
+ double positive
(DP), CD4
+CD8
- single positive (CD4 SP) or CD4
-CD8
+ single
positive (CD8 SP) thymocytes by FACS (data not shown). Little or
no miR-10a signal was observed in DN thymocytes and no signal
was detected in DP or CD8 SP thymocytes. CD4 SP cells
expressed miR-10a levels comparable to DN cells (Fig. 2a).
However, when the CD4
+ SP cells were subdivided into GFP
- and
GFP
+, i.e. FoxP3 expressing cells versus Tconv thymocytes, a clear
signal was observed only in the CD4
+ SP GFP
+ natural Treg
(nTreg) population (Fig. 2a). Reproducibility of this experiment is
shown in Fig. S1. Next we examined the relationship between
miR-10a and FoxP3 expression. We took advantage of the
recently described lineage tracing strategy [2]. Individual CD4
+
thymocyte subpopulations were purified including GFP
-YFP
- cells
that do not express FoxP3 (and never did), GFP
+YFP
- cells where
FoxP3 was turned on but cre activity was not sufficient to result in
detectable YFP protein levels yet, and GFP
+YFP
+ which
represented actively expressing ‘‘bona fide’’ nTreg as a means to
determine the temporal expression of miR-10a during thymic
nTreg development (Fig. 2b). Neither GFP
-YFP
- nor GFP
+YFP
-
cells expressed miR-10a, while there was significant miR-10a
expression in thymic GFP
+YFP
+ Treg suggesting that miR-10a
expression occurs temporally after FoxP3 expression (Fig. 2b). We
can not exclude that a small part of the miR-10a signal detected in
GFP
+YFP
+ Treg stems from recirculating Treg. Nevertheless, the
result demonstrates that within thymocytes miR-10a expression is
restricted to Treg (independent of their origin of generation) and
FoxP3 expression precedes miR-10a expression.
Next, we analyzed miR-10a expression in peripheral T cell
subsets. As noted previously, miR-10a is expressed in Treg but not
bulk CD4
+ or CD8
+ Tconv cells (data not shown). Of note, miR-
10a levels in exFoxP3 cells (GFP
-YFP
+) were equal or slightly
higher to Tconv (GFP
-YFP
-) levels but much lower than in nTreg
cells (GFP
+YFP
+) (Fig. 2c) illustrating a tight correlation between
FoxP3 and miR-10a expression suggesting that miR-10a may be a
stabilizing factor of Foxp3 expression. Reproducibility of exper-
iments shown in Fig. 2b and Fig. 2c is shown in Fig. S2. In
summary, miR-10a marks Treg cells in thymocytes, LN and
spleen but not other T cell subsets such as early thymocytes, bulk
CD4
+, and CD8
+ T cells.
All-trans Retinoic Acid but Not TGF-ß Induces miR-10a in
CD4
+ T Cells
The highly specific miR-10a expression in Tregs led us to
investigate inductive signals. Neither T cell activation by
stimulating purified CD4
+CD25
- cells with anti-CD3 and anti-
CD28 did induce miR-10a (data not shown) nor in vitro skewing
into Th1 and Th17 cells increased miR-10a expression above
levels seen under neutral culture conditions (data not shown)
suggesting that miR-10a expression is limited to the FoxP3
+ T cell
lineage. Multiple studies have shown that in vitro T cell activation
in the presence of TGF-ß can induce FoxP3 in Tconv to generate
CD4
+FoxP3
+ iTreg. However, the transcriptome of iTreg
significantly differs from nTreg indicating that additional signals
might be involved during physiological nTreg development [9].
Importantly, iTreg are not as stable as nTreg since withdrawal of
TGF-ß results in a loss of FoxP3 while ex vivo purified nTreg
maintain high FoxP3 expression independent of TGF-ß [10].
Since we detected miR-10a in nTreg but reduced levels in
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Figure 1. Treg miRNA expression signature. a) miRNA microarray
analysis of CD4
+CD25
-GFP
- (Tconv) and CD4
+CD25
hiGFP
+ (Treg cells)
purified from lymph nodes from female FoxP3-GFP-hCre reporter mice.
Shown are 4 technical replicates from the same slide (one biologic
replicate). b) qPCR of relative miR-10a expression by sorted Tconv (GFP
-)
and Treg (GFP
+). One representative example of .7 independent
experiments from .7 independent biologic replicates. Error bars: SD of
technical triplicates.
doi:10.1371/journal.pone.0036684.g001
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Figure 2. miR-10a marks Treg cells. qPCR analysis of relative
expression of miR-10a in purified T cells. a) Thymocytes: CD4
-CD8
-
double negative (DN), CD4
+CD8
+ double positive (DP), CD4
+CD8
- single
positive (CD4SP), CD8
+CD4
- single positive (CD8SP), CD4
+CD8
-FoxP3-
GFP
- (CD4SP GFP
-) and CD4
+CD8
-FoxP3-GFP
+ (CD4 SP GFP
+). b) CD4 SP
FoxP3-GFP
-R26YFP
- (GFP
-YFP
-), CD4 SP FoxP3-GFP
+R26YFP
- (GFP
+YFP
-)
and CD4 SP FoxP3-GFP
+R26YFP
+ (GFP
+YFP
+) thymocytes. c)
CD4
+GFP
-YFP
- (Tconv), CD4
+GFP
+YFP
+ (nTreg) and CD4
+GFP
-YFP
+
(exFoxP3) cells purified from pooled LN and spleen. Shown is one
representative experiment from four (a) and two (b, c) independent
experiments. Error bars: SD of triplicates.
doi:10.1371/journal.pone.0036684.g002
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PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36684unstable exFoxP3 cells (Fig. 2a-c) we tested miR-10a levels in
TGF-ß-induced iTreg cells, hypothesizing that like exFoxP3 cells
they would have reduced miR-10a expression. Indeed, despite
substantial FoxP3 (GFP) induction (data not shown) miR-10a was
not induced in GFP
+ cells (Fig. 3). These results suggest that FoxP3
expression alone is not sufficient to drive miR-10a expression.
All-trans-retinoic acid (RA), the oxidized form of Vitamin A has
been shown to play a role in the conversion of Tconv into FoxP3
+
adaptive regulatory T cells (aTreg) and may play a critical role in
iTreg stability [11]. Although the precise molecular mechanism
remains controversial, it is well accepted that the net result of
combined RA/TGF-ß-treatment of Tconv is enhanced FoxP3
induction compared to TGF-ß alone. We tested if RA could
induce miR-10a in T cells. RA alone or in combination with TGF-
ß induced miR-10a (Fig. 3). Although RA-treated GFP
- (FoxP3
-)
cells did express low levels of miR-10a in the absence of TGF-ß,
the presence of TGF-ß synergized to maximally induce miR-10a.
This effect was specific as expression of miR-16 and miR-155 was
not induced (Fig. 3). Reproducibility of this experiment is shown in
Fig. S3. In summary, RA but not TGF-ß alone can induce miR-
10a in conventional CD4
+ T cells.
Treg-specific miR-10a Modulates FoxP3 Stability in vitro
Our understanding of the molecular mechanisms that maintain
Treg stability remain uncertain although miRNAs do stabilize
Treg lineage identity [4]. Based on its expression, we hypothesized
that miR-10a might facilitate/maintain high and stable FoxP3
levels. Therefore, we cultured nTreg in the presence of
antagomiR-10a or antagomiR-155 [12]. Antagomirs specifically
inhibited the targeted miRNA (data not shown). Fluorescently
labeled (DY547) antagomiR-10a demonstrated a very high
transfection rate (.90%) as previously reported for other cell
types (Fig. 4a) [13]. Uptake was evident within a few minutes after
treatment and neared saturation after 12 h (Fig. 4a). AntagomiR-
10a treatment of nTreg led to a dose-dependent reduction of GFP
(data not shown) and FoxP3 in nTregs compared to antagomiR-
155 (Fig. 4b). CD4 expression was not changed by any antagomiR
confirming the specificity of the inhibitors (data not shown).
Together these results suggest that high FoxP3 levels in nTreg cells
are positively controlled by miR-10a.
miR-10a is Dispensable for TGFb and Retinoic Acid-
mediated FoxP3 Induction
To test if miR-10a was required for RA-mediated iTreg
induction we purified naı ¨ve CD4
+CD62L
hi25
2 Tconv and
activated them in vitro with anti-CD3 and anti-CD28 mAb in
the presence of RA, TGFb or a combination of the two. RA
induced FoxP3 in very few cells. TGFb induced FoxP3 in .70%
of cells and combining RA and TGFb induced FoxP3 in almost all
cells (Fig. 5a). However, there was no difference between miR-10a
sufficient and miR-10a-deficient cells (Fig. 5b). Thus, miR-10a is
dispensable for FoxP3 induction.
miR-10a Expression in Treg Inversely Correlates with
Susceptibility to Autoimmune Disease
NOD mice have increased frequencies of exFoxP3 cells in islets,
an indication of a defect in Treg stability [2]. Therefore, we
determined miR-10a expression levels in diabetes-prone NOD
and autoimmune-resistant B6 Treg cells (CD4
+CD25
+CD62L
hi).
As observed in non-autoimmune prone mice (Fig. 1 and 2), NOD
Treg expressed miR-10a but at much lower levels than their B6
counterparts (Fig. 6a). To test whether miR-10a levels in Treg cells
correlated with autoimmune susceptibility, we screened various
inbred mouse strains for Treg-specific miR-10a expression. Treg
from autoimmune-resistant B6 mice had the highest miR-10a
expression while Treg from autoimmune-prone NOD mice had
the lowest (Fig 6b). Mouse strains with more variable susceptibility
to autoimmune disease (BALB/c, 129, DBA/2J) had intermediate
expression levels. Thus, we found an inverse correlation of Treg-
specific miR-10a expression with susceptibility to autoimmune
disease.
Discussion
Given the opposing roles of regulatory versus conventional
helper CD4
+ T cells, it is puzzling how few protein-coding genes
are differentially expressed among these T cell subsets. Most
differences are quantitative rather than qualitative [9], yet, the
sum of differential gene expression is sufficient to imprint highly
specialized functions in each subset. Likewise, the only miRNA
specific for Treg cells was miR-10a. Interestingly, miR-10a
expression seems to be specifically induced in Treg since the two
flanking protein-coding genes are not detectable (HoxB5) or barely
expressed (HoxB4) in naive, Th1, Th2, Th17, induced Treg
(iTreg) or nTreg [14]. These observations suggest that thymic
Treg sense a signal to actively and specifically induce miR-10a.
The expression data suggests a correlation with more stable
Treg and combined with the in vitro data supports the possibility
that this miRNA may be involved in long-term maintenance of
Treg stability. Interestingly RA, secreted by a specialized subset of
CD103
+ dendritic cells, is important for inducing Treg in the gut
[11,15,16]. More importantly, in contrast to TGF-ß alone, the
combination of TGF-ß and RA not only increases the frequency of
FoxP3 expressing T cells in vitro but the induced FoxP3
+ cells are
more stable, particularly in an inflammatory environment [11,17].
Given the strong induction of miR-10a by RA, the added benefit
of RA might partially be accomplished through miR-10a, which is
embedded in the HoxB cluster, a genomic region with known RA
responsiveness. In a pancreatic cancer cell line RA directly binds
to a retinoic acid response element (RARE) in the HoxB cluster
and induces miR-10a [18]. Therefore, it seems likely that in T cells
RA directly induces miR-10a through direct binding of RARE
elements in the HoxB/miR-10a locus. Pharmacologic miR-10a
inhibition did indeed inhibit the expression level of miR-10a.
However, miR-10a-deficient mice are fertile and age without
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Figure 3. All-trans retinoic acid but not TGF-ß induces miR-10a
in CD4
+ T cells. FACS-purified CD4
+CD62L
hiGFP
- cells from FoxP3-GFP
reporter mice were cultured with plate-bound anti-CD3 and anti-CD28
antibodies +/2 TGF-ß and/or retinoic acid. After 72 h the CD4
+GFP
- and
CD4
+GFP
+ cells were purified by flow cytometry for RNA extraction.
miRNA levels were assessed by qPCR in technical triplicates. Shown is a
representative experiment of two independent experiments. Error bars:
SD of triplicates.
doi:10.1371/journal.pone.0036684.g003
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lished results). Treg numbers and phenotype appear normal under
homeostatic conditions (data not shown) and miR-10a was
dispensable for FoxP3 induction in naı ¨ve T cells. Furthermore,
miR-10a-deficient Treg cells suppress colitis in an adoptive
transfer model (Jeker & Bluestone, unpublished results). Yet, the
importance of this miRNA may only be apparent under certain
pathogenic or other stress settings [3,19,20] and deKouchkovsky
et al., MS submitted. This notion is supported by the fact that
NOD Treg express very low levels of miR-10a without NOD mice
developing scurfy-like disease and miR-10a-deficient Treg are
present in normal numbers and express normal levels of FoxP3
(data not shown).
How can the discrepancy between in vitro inhibition of miR-
10a expression with antagomiRs versus genetic ablation be
explained? It is possible that antagomiR-10a had off-target effects,
e.g. inhibition of miR-10b and miR-125a, which has sequence
homology or interaction with other targets. In fact, antagomiR-
125a did reduce FoxP3 expression to some extent (although to a
lesser degree than antagomiR-10a) but the combination of
antagomiR-10a and antagomiR-125a did not further enhance
FoxP3 downregulation (data not shown). Alternatively, miR-10b
might compensate for the absence of miR-10a in miR-10a-
deficient Treg, since miRNAs are often redundant [21]. Tempo-
rally controlled conditional miR-10a ablation might reveal its
function [22]. Finally, miR-10a might be expressed and functional
only in a subset of Treg as it has become clear that
CD4
+CD25
+FoxP3
+ cells are heterogeneous and may be func-
tionally diverse, depending on tissue location and activation status
[23,24].
In summary, further studies are required to investigate miR-10a
function in vivo. Despite an intriguing expression pattern, we were
not able to define the miR-10a function in Treg in vivo.
Importantly, our results suggest that phenotypic effects obtained
using antagomiRs and possibly other classes of pharmacological
miRNA inhibitors should be interpreted with a certain degree of
caution. Of note, similar discrepancies between pharmacological
miRNA inhibition and genetic ablation have been described for
another miRNA and other pharmacologic inhibitors [13,25].
In summary, it appears that Treg do not express a specific
miRNA essential for Treg function. Although absence of all
miRNAs leads to spontaneous scurfy-like disease [4,5,6], no
individual miRNA required for Treg function under homeostatic
conditions has been described yet. The Treg-enriched miRNAs
miR-155 and miR-10a are on their own largely dispensable for
global Treg function under homeostatic conditions in vivo [26] and
data not shown. Even the role of miR-146a remains unclear as the
studies of miR-146a-deficient Tregs involved the co-transfer of
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Figure 4. Treg-specific miR-10a modulates FoxP3 stability in vitro. FACS-purified CD4
+CD62L
hiGFP
+ cells from FoxP3-GFP reporter mice were
cultured with anti-CD3 and anti-CD28 beads and 2000U IL-2/ml for 48 h. Time course of antagomiR-DY547 transfection in cultured Treg (a). FoxP3
staining 48 h after culture in the presence of 50 mg/ml antagomiR-155 or antagomiR-10a (b). Grey shaded histograms represent nontransfected cells,
black lines represent cells treated with antagomiR. Shown is one experiment (a) and one representative experiment from three (b) independent
experiments.
doi:10.1371/journal.pone.0036684.g004
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36684Figure 5. miR-10a is dispensable for TGFb and retinoic acid-mediated FoxP3 induction. Naı ¨ve CD4
+CD25
-CD62L
hi Tconv were activated
with anti-CD3 and anti-CD28 in the presence of RA, TGFb or a combination of the two. Cells were from wildtype (‘‘control’’) or littermate miR-10a-
deficient (‘‘ko’’) mice. Representative of 4 independent experiments.
doi:10.1371/journal.pone.0036684.g005
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e36684miR-146a-deficient Treg along with miR-146a-deficient hyper-
reactive IFN-c secreting Teff and scurfy bone marrow as well as a
pre-transplant preconditioning regimen [27]. Therefore, the
function of miR-146a in Tregs under homeostatic conditions has
not been determined. Thus, the absence of the protective layer of
multiple miRNAs may predispose Treg to dysfunction, particu-
larly in an inflammatory milieu and might constitute a risk factor
for the development of autoimmune disease but absence of several
individual miRNAs does not lead to complete Treg dysfunction.
Materials and Methods
RNA Isolation
Total RNA was extracted using Qiagen’s miRNeasy kit or
Trizol (Invitrogen).
miRNA Arrays
CD4
+CD25
2GFP
2 conventional T cells (Tconv) and
CD4
+CD25
hiGFP
+ Treg from pooled axillary, cervical and
inguinal lymph nodes from three pooled female FoxP3-GFP-hCre
reporter mice were sorted on a Moflo flow cytometer [4]. Total
RNA was extracted using Qiagen’s miRNeasy kit according to the
manufacturer’s protocol; RNA integrity was tested using an
Agilent Bioanalyzer Chip. 300 ng total RNA each was hybridized
to Exiqon MirCury V9.2 arrays. Slides were scanned using
GenePix Pro 6.0.0.29 on a GenePix 4000B scanner at 10 mm. All
data is MIAME compliant and the raw data has been deposited in
Gene Expression Omnibus (GEO), accession number GSE30847.
miRNA RT-qPCR
RNA was isolated as described above. 20–30 ng total RNA
were used for reverse transcription (RT) if not indicated otherwise.
RT reactions were performed with ABI’s TaqMan MicroRNA
RT kit (Cat No 4366596) according to the manufacturer except
for using only 50% of the recommended volumes for the Applied
Biosystems kits. PCR reactions were performed on 1 mlR T
product with 50% of the recommended volumes for ABI reagents.
As indicated, for some experiments primers and probes were
designed as described [28] and ordered from Integrated DNA
Technologies (IDT) using the following sequences: http://urology.
ucsf.edu/blellochlab/protocols/miRNAqPCRsequences.txt.
Figure 6. miR-10a expression in Treg inversely correlates with susceptibility to autoimmune disease. qRT-PCR for miR-10a expression
by FACS-purified CD4
+CD25
+CD62L
hi Treg. a) Amplification plots for miR-10a on Treg cDNA from B6 and NOD mice. The sno202 signal for B6 and
NOD completely overlapped. The signal for Tconv is comparable to miR-10a in NOD Treg (data not shown). b) Relative miR-10a expression in Treg
from B6, 129X1/SvJ, 129S6/SvEvTac, DBA/2J, BALB/c and NOD/ShiLtJ mice. Bars represent means of pooled data from 3 (B6), one (129X1/SvJ), one
(129S6/SvEvTac), 2 (DBA/2J), one (BALB/c) and 3 (NOD/ShiLtJ) biologic replicates. Error bars: SEM. All samples were normalized to miR-10a expression
in BALB/c mice.
doi:10.1371/journal.pone.0036684.g006
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36684Annealing temperatures for IDT reactions were: mmu-miR-
10a, mmu-miR-16, mmu-miR-155, hsa-miR-155:47.5uC. All
reactions were normalized to sno202, measured with the ABI kit
mouse snoRNA202 TaqMan assay, identification # 1232, (Cat
No 4380914).
Antagomirs
Antagomirs were designed as described [12]. Briefly, RNA
molecules 100% complementary to the mature miRNA to be
antagonized were synthesized by Integrated DNA Technologies
(IDT www.idtdna.com) with the following rules: a) .19nt length
b) 39 Cholesterol moiety c) complete 29-O-methylation d)
phosphorothioate linkage: first two nt at 59 end and 4 nt at 39
end. Specific sequences are shown in Table S2. Lyophilized
antagomiRs were reconstituted in H2O and directly added to the
culture medium with at least dilutions of 1:50.
Mice
miR-10a-deficient mice were backcrossed for .7 generations to
B6 (Gustavo Stadthagen & Anders Lund, unpublished results).
C57BL/6J (stock Number 000664), NOD/ShiLtJ (Stock Number
001976), 129X1/SvJ (stock number 000691), DBA/2J (stock
Number 000671) and BALB/cJ (stock number 000651) were
purchased from the Jackson laboratories. 129S6/SvEvTac were
purchased from Taconic. Foxp3-GFP-hCre and ROSA26-YFP
mice have been described [4]. Mice were housed and bred under
specific pathogen-free conditions at the University of California,
San Francisco (UCSF) Animal Barrier Facility. Animal experi-
ments were approved by the Institutional Animal Care and Use
Committee (IACUC) of UCSF, approval numbers AN083988-01
and AN082188-02.
Antibodies, Flow Cytometry and FACS Sorting
Flow cytometry and fluorescence activated cell sorting was
performed as described [2,4].
iTreg Induction
After staining with mAb anti-CD4 PE-Cy7 (clone RM4-5) naı ¨ve
CD62L
hiCD4
+GFP
- cells were sorted from pooled LN (axillary,
cervical, inguinal, mesenteric, pancreatic and pelvic para-aortal)
and spleen cells [8], activated with anti-CD3 (2C11)/anti-CD28
(PV-1) mAbs (0.5 mg/ml each) with 20 ng/ml human recombinant
TGF-b (R&D). Retinoic acid (Sigma Aldrich R2625) diluted in
DMSO (Sigma Aldrich) was added at 2.5 nM final concentration.
After 4 or 5 days cells were harvested, washed, counted and
stained with mAb anti-CD4 Alexa647 (clone GK1.5), then
purified with a MoFlo cell sorter into GFP
2 and GFP
+ CD4
+ T
cells.
Data Presentation
We present the data according to the editorial ‘‘How robust is
your data?’’, Nature Cell Biology, June 1, 2009. Figures show
representative experiments but multiple individual experiments
were provided as supporting online Figures to demonstrate
reproducibility. Specifically, Fig. S1 shows individual experiments
related to Figure 2a. Fig. S2 shows individual experiments related
to Figure 2b,c and Fig. S3 shows individual experiments related to
Figure 3.
Supporting Information
Figure S1 Reproducibility of the applied miRNA qPCR
approach. Shown are all 4 individual experiments for main
Figure 2a, demonstrating the high reproducibility of the applied
qPCR technology. Experiment 2 is shown in Figure 2a. All
experiments were performed on different days using separate mice.
(EPS)
Figure S2 Reproducibility of the applied miRNA qPCR
approach. A: The second experiment performed to generate
Figure 2. B-E: Individual experiments performed to generate
Figure 2b and 2c. B+C: The same experiment, LN and spleen
analyzed separately. D: Different experiment than in B+C, done
on a different day with a different mouse. This time LN and spleen
cells were pooled. E: Different experiment than in B+C, done on
the same day as D but with a different mouse. LN and spleen cells
were pooled.
(EPS)
Figure S3 Reproducibility of the applied miRNA qPCR
approach. Shown are both individual experiments performed for
main Figure 3. Experiment 1 is shown in the main Figure 3
because the fold change is less extreme. Like Figures S1 and S2
this demonstrates the high reproducibility of the applied qPCR
technology. We believe that for the conclusions drawn, the pattern
of miRNA expression is more important than the fold change.
Both experiments were performed on different days using different
mice.
(EPS)
Table S1 Tconv and Treg miRNA expression signature.
300 ng total RNA was hybridized for Tconv and Treg to Exiqon
MirCury V9.2 arrays. miRNA name (Column A), Fluorescence
values of GFP- Tconv (Cy5) (Column B) and GFP+ Treg (Cy3)
(column C). Fold fluorescence difference of Treg/Tconv (Column
D). Background fluorescence, indicated as B635 and B532, was
subtracted from total fluorescence for each spot on the slide.
(XLS)
Table S2 AntagomiR sequences. Nucleotide sequence and
chemical modifications of antagomiR sequences used.
(XLS)
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